Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Polymorph Control . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1122036C reveals a robust method for producing stable Olanzapine Form II via dihydrate intermediates, ensuring high purity and solvent-free formulations for pharmaceutical manufacturing.
Advanced recrystallization technology removes critical impurity imA from Mirabegron. Enhances purity to over 99.9 percent for reliable pharmaceutical supply chains.
Patent CN102260244B details a stable rabeprazole sodium synthesis with 99.9% purity. Offers superior moisture stability and cost-effective manufacturing for global supply chains.